Julia Morizzi

Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria

Susan A. Charman, Sarah Arbe‐Barnes, Ian Bathurst et al. · Proceedings of the National Academy of Sciences · 2011 · 376 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinase

Tanya Paquet, Claire Le Manach, Diego González Cabrera et al. · Science Translational Medicine · 2017 · 272 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

An in vitro toolbox to accelerate anti-malarial drug discovery and development

Susan A. Charman, Alice Andreu, Helena Barker et al. · Malaria Journal · 2020 · 158 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Diacetylbis(N(4)-methylthiosemicarbazonato) Copper(II) (CuII(atsm)) Protects against Peroxynitrite-induced Nitrosative Damage and Prolongs Survival in Amyotrophic Lateral Sclerosis Mouse Model

Cynthia P.W. Soon, Paul S. Donnelly, Bradley J. Turner et al. · Journal of Biological Chemistry · 2011 · 152 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Discovery of 7-Hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[<i>b</i>]furan (BNC105), a Tubulin Polymerization Inhibitor with Potent Antiproliferative and Tumor Vascular Disrupting Properties

Bernard L. Flynn, Gurmit S. Gill, Damian Grobelny et al. · Journal of Medicinal Chemistry · 2011 · 139 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17